EAU26 poster highlight (P0183): ASCVD score in suspected vasculogenic ED—risk stratification helps align ED severity with broader cardiovascular prevention needs and supports integrated referral pathways.
#EAU26 #Urology #Andrology #SexualMedicine #ErectileDysfunction #ASCVD #UroSoMe

EAU26 poster highlight: ZSI 475 FTM penile implants following phalloplasty — multicentre retrospective cohort (Levy)
IJIR paper: rdcu.be/e8fhU
#EAU26 #Urology #ReconstructiveUrology #GenderAffirmingSurgery #Phalloplasty #PenileProsthesis #UroSoMe

EAU26 poster highlight: Depression in Peyronie’s disease (binational Australia–Denmark cohort).
More on Peyronie's disease and mental health: rdcu.be/e8Qql
#EAU26 #Urology #Andrology #SexualMedicine #PeyroniesDisease #MentalHealth #UroSoMe

EAU26 poster highlight: Corporal Flow Reserve (CFR) assessed via dynamic penile Color Doppler—translating a cardiology “flow reserve” paradigm to evaluate arteriogenic ED.
#EAU26 #Urology #Andrology #SexualMedicine #ErectileDysfunction #UroSoMe

EAU26 highlight: FTM gender-affirming surgery — reconstructive targets: adequate size, standing urination, tactile/erogenous sensation, and penetrative sexual function.
@uroweb.org
#EAU26 #Urology #ReconstructiveUrology #GenderAffirmingSurgery #Phalloplasty #UroSoMe

EAU26 highlight: When there’s not enough skin — “lack of skin” ≠ just quantity; think tethering/tension first (release contracture, find the cause, position test).
@uroweb.org @SkrodzkaM @GeorgesUrology
#EAU26 #Urology #ReconstructiveUrology #Andrology #UroSoMe

EAU26 highlight: Distal urethral stricture — “the final frontier”
#EAU26 #Urology #ReconstructiveUrology #UrethralStricture #UroSoMe

EAU26 highlight: History lecture — “What can we learn from past mistakes in genital surgery?”
J.C. Goddard (Leicester, GB).
@uroweb.org
#EAU26 #Urology #ReconstructiveUrology #GenitalSurgery #PatientSafety #MedicalEthics #UroSoMe

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

Flashback to our 2019 interview day, our fellow grads from 2022: (L) Dr. Jared Schober, now at U Nebraska (R) Dr Kevin Ginzburg, now at Wayne State

Getting ready to host Fox Chase Cancer Center SUO fellowship interviews. Excited to be back in-person for the first time since these superstars!
#UroEd #UroSome

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

#ASCO #GU26
Day 2 —it’s urothelial cancer day!
#UroSome

A Cornell urology residency alum presenting the Keynote address for Philly Urologic (PUS)

Two old guys who trained together in urology starting at the end of the last century

Great to see Jaspeet Sandhu @mskcancercenter.bsky.social in town to give the Philadelphia Urologic Society B.A. Thomas lecture—a leader in urology cancer survivorship. Has it really been over 25 yrs since we were at The Brady? #CornellMafia
#UroSoMe #UroSky

🧬 Missed our webinar on microRNA studies in testicular germ cell tumours?

📺 Watch now: youtu.be/ezg8w7SkOw8

📰 Subscribe: tinyurl.com/ERNeUROGENne...

#EUfunded #EU4Health #RareDisease #ERNs #UroOnc #EUCancerPlan #EUCancerMission #UroSoMe
@ec.europa.eu @jardinjointaction.bsky.social

🎥 Watch our webinar on Adrenal Cancer and Malignant Cysts with Hans Langenhuijsen & Nikola Knežević

📺 youtu.be/NK8dsUHF_dU

📰 tinyurl.com/ERNeUROGENne...

#EUfunded #EU4Health #RareDisease #ERNs #UroOnc #EUCancerPlan #EUCancerMission #UroSoMe @ec.europa.eu @jardinjointaction.bsky.social

Hey, let’s get you over here. Maybe double post here and that other place and see if we can increase the traffic to a critical mass. #UroSoMe

⚠️ Missed our cross-ERN webinar on medical device shortages & regulatory barriers?

🎥 Now on YouTube: www.youtube.com/watch?v=QGvG...

📰 Subscribe: bit.ly/4j7MaHU

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #UroSoMe @ec.europa.eu @jardinjointaction.bsky.social

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #UroSoMe

EV-103 Cohort K: long-term outcomes of EV ± pembrolizumab in la/mUC - VJOncology Terence Friedlander, MD, University of California, San Francisco, CA, discusses updated results from Cohort K of the Phase Ib/II EV-103...

Terence Friedlander, MD, shares 3.5-year #EV103 Cohort K data at #ESMO25 — enfortumab vedotin + pembrolizumab continues to show durable responses & survival benefits in 1L la/mUC.

🎥 Watch: buff.ly/kWn5KkI

#UroOnc #UroSoMe #Blcsm #ImmunoOnc #CTSM #TrialUpdate

EMBARK: final OS results of enzalutamide in hrBCR prostate cancer - VJOncology Neal Shore, MD, FACS, Carolina Urologic Research Center, Myrtle Beach, SC, discusses final overall survival results from the Phase III...

Neal Shore, MD, FACS shares final OS data from EMBARK in high-risk BCR prostate cancer.

💊 Enzalutamide + leuprolide ↓ risk of death vs leuprolide alone
📈 Improved progression & skeletal outcomes
✅ Confirms enzalutamide-based therapy as SoC
🎥 buff.ly/LBEmrOa

#ProstateCancer #ESMO25 #UroOnc #UroSoMe

FORAGER-1: dose optimization of LY3866288 in FGFR3-altered tumors - VJOncology Alexandra Drakaki, MD, PhD, University of California, Los Angeles, CA, discusses the Phase I FORAGER-1 study (NCT05614739) of LY3866288, a...

Alexandra Drakaki, MD, PhD, discusses FORAGER-1 testing LY3866288 in FGFR3-altered tumors

🧬 200 mg BID = well tolerated
💥 Encouraging antitumor activity in mUC
🧪 Activity seen post-FGFR inhibitor exposure

🎥 buff.ly/ozWqgdG

#BladderCancer #Blcsm #UroOnc #UroSoMe #CTSM #TrialUpdate #ESMO25

COSMIC-313: transcriptomic predictors of metastatic sites in RCC - VJOncology Clara Steiner, MD, Dana-Farber Cancer Institute, Boston, MA & University Hospital Leipzig, Leipzig, Germany, discusses a post-hoc transcriptomic analysis from...

Clara Steiner, MD, presents new transcriptomic findings from COSMIC-313 in #RCC at #ESMO25

🧬 RNA sequencing of baseline tumors
🔍 Distinct gene signatures by metastasis site
🌡️ Pathways: metabolism, hypoxia, EMT

🎥 Watch: buff.ly/dIMvnoC

@myesmo.bsky.social #KCSM #CTSM #TrialUpdate #UroOnc #UroSoMe

🧠 Missed our webinar on Interstitial Cystitis & Complex Bladder Pain Syndrome? Dr. Lisa Moris shares a multidisciplinary approach.

📺 youtu.be/C9yFFx06I24
📰 bit.ly/4j7MaHU

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #FPMRS #UroSoMe

PSMAddition: 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC - VJOncology Scott Tagawa, MD, MS, FACP, Weill Cornell Medical Center, New York, NY, discusses the Phase III PSMAddition trial (NCT04720157), which...

At #ESMO25, Scott Tagawa, MD, MS, FACP, discusses the Phase III PSMAddition trial in PSMA-positive mHSPC:

💥 Adding ¹⁷⁷Lu-PSMA-617 to ADT + ARPI improved rPFS
📈 OS trend & manageable safety
✅ No major QoL impact

🎥 Watch: buff.ly/vSBfVPS

@myesmo.bsky.social #PCSM #UroOnc #UroSoMe #RadOnc #CTSM

CheckMate 274: 5-year results of adjuvant nivolumab in MIUC - VJOncology Clara Steiner, MD, Dana-Farber Cancer Institute, Boston, MA & University Hospital Leipzig, Leipzig, Germany, gives an overview of updated 5-year...

At #ESMO25, Clara Steiner, MD, presents 5-year results of CheckMate 274 in MIUC

💊 Adjuvant nivolumab vs placebo after surgery
📈 Sustained DFS, OS & disease-specific survival benefit
🧫 ctDNA-positive pts saw enhanced benefit
✅ No new safety concerns

🎥 Watch: buff.ly/ou4EvLv

#UroOnc #UroSoMe #Blcsm

RENALUT: 177Lu-PSMA-617 in metastatic pre-treated ccRCC - VJOncology Emmanuel Seront, MD, PhD, Cliniques Universitaires Saint Luc, Brussels, Belgium, discusses the Phase II RENALUT (NCT06783348) of 177Lu-PSMA-617 in patients...

At #ESMO25, Emmanuel Seront discusses the RENALUT trial of ¹⁷⁷Lu-PSMA-617 in metastatic ccRCC

💥 PSMA-targeted radioligand therapy after TKI + ICI progression
🎯 Evaluating response, PFS, OS, & safety
🧠 Imaging-guided treatment w/ added cycles for responders

🎥 buff.ly/sswLUyk

#kcms #UroOnc #UroSoME

Our team joined the Testicular Cancer Awareness Foundation for the 10th Annual Testicular Cancer Conference in Boston. It was an inspiring weekend with survivors, patients, caregivers, medical experts, and researchers.

#TesticularCancer #UroSoMe #urology #MensHealth #TCAF

RAISN: indocyanine green-guided lymph node dissection in testicular cancer - VJOncology Yue Che, MD, University Hospital of Duesseldorf, Düsseldorf, Germany, discusses the evolving role of retroperitoneal lymph node dissection and therapy...

⭐ Yue Che, MD, shares RAISN trial: ICG-guided sentinel node biopsy is feasible & well tolerated in stage I testicular cancer, aiming to reduce chemo use:

🎥 buff.ly/kF09jHH

#EAU25 #UroOnc #UroSoMe #CTSM #TrialUpdate #TSCsm